Sangamo Therapeutics Inc (SGMO) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Sangamo Therapeutics Inc (SGMO) Precio de Acción, Cotización, Noticias e Historial

SGMOOTC

Trade with Public

Trade with Public

$0.0740

-0.10-58.33%

Últ. Act.: Jun 23, 3:59 PM

$0.0777

-0.0999-56.25%

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

-

Cierre

-

Volumen / Prom.

0 / -

Rango diario

- - -

Rango de 52 semanas

0.06 - 0.76

Capitalización bursátil

-

Ratio PER

-

Rentabilidad por dividendo

-

Exchange

OTC

RSI

-

Interés en corto

-

Días para cubrir

4.13

Noticias Recientes de Sangamo Therapeutics Inc

Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle

Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.

Vandana Singh

Deal Dispatch: Carlyle Buys Chung Ho Group, Second Nature Brands Acquires Tillamook Country Smoker, GoHealth Bankruptcy

SGMO explores strategic alternatives, ZOOZ considers complementing bitcoin strategy, Arcline acquires Continental, Mill Point buys Total Safety, Carlyle acquires Chung Ho Group.

Caroline Ryan

Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings

Avi Kapoor

Dow Falls 100 Points; Brinker Earnings Beat Estimates

US stocks lower, Dow falls 100 points. Energy shares up 1%, communication services down 0.7%. Brinker beats earnings, raises guidance. SAGT up 79%.

Avi Kapoor

Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its second SpaceShip is expected to enter service soon, causing a 6% jump in pre-market trading. Other gainers included ARTL, AFBI, and BIRD, while PEPG and PHR were among the losers.

Avi Kapoor

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Calificación de analistas

2.3

Venta

Compra fuerte

Compra

Mantener

Venta

Venta fuerte